Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.404 SEK | -3.17% | -4.49% | -69.11% |
05-03 | Kancera AB Reports Positive Results from the Clinical Phase I Study with KAND145 in Healthy Subjects | CI |
02-23 | Kancera AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
- Stock Market
- Equities
- KAN Stock
- News Kancera AB
- Other languages